Open AccessEffectiveness comparisons of acupuncture for chronic prostatitis/chronic pelvic pain syndrome
Author(s) -
Yi Lee,
Xueyun He,
Jingshang Wang,
Xiaoyong Gong,
Wei Zheng,
Yansong Xue,
Yongqiang Li,
Zhenmin Bao,
Jiajia Ma,
Chaohui Xue
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000015199
Subject(s) - medicine , prostatitis , chronic prostatitis/chronic pelvic pain syndrome , cochrane library , acupuncture , meta analysis , pelvic pain , medline , randomized controlled trial , grading (engineering) , physical therapy , quality of evidence , population , alternative medicine , surgery , pathology , prostate , civil engineering , environmental health , cancer , political science , law , engineering
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urinary system disease in the male population. Recent studies have shown that acupuncture can alleviate the pain caused by CP/CPPS to a certain extent and improve the quality of life of patients. This study used a network meta-analysis (NMA) to compare the effectiveness and safety of different forms of acupuncture on CP/CPPS. Methods and analysis: We will search for PubMed, Cochrane Library, AMED, EMbase, WorldSciNet; Nature, Science online and China Journal Full-text Database, China Biomedical Literature CD-ROM Database, and related randomized controlled trials (RCTs) included in the China Resources Database. The time is limited from the construction of the library to December 2018. The quality of the included RCTs will be evaluated with the risk of bias tool and evidence will be evaluated by grading of recommendations assessment, development, and evaluation. STATA 13.0 and WinBUGS 1.4.3 through the GeMTC package will be used to perform a NMA to synthesize direct and indirect evidence. Results: The results of this NMA will be submitted to a peer-reviewed journal for publication. Trial registration number: PROSPERO CRD42018111408.